Infections in acute myeloid leukemia: an analysis of 382 febrile episodes
Authors:
- 15 October 2009
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 27 (4) , 1037-1045
Abstract
Neutropenic fever is an important cause of morbidity and mortality during therapy of acute myeloid leukemia (AML). We retrospectively analyzed 382 febrile episodes encountered during induction and consolidation chemotherapy to determine the potential etiology, microbiologic spectrum, response/resistance to antibiotics and outcome. Between May, 2001 and December, 2006, 95 patients with de novo non-M3 AML received remission induction chemotherapy followed by consolidation in those who achieved complete remission. Patients median age was 28 years, ranging from 2 to 61 years, 26 patients were ≤15 years of age. There were 57 males and 38 females. Febrile neutropenia was defined as per international guidelines. A total of 382 febrile episodes were recorded; neutropenic 347 (induction phase 172, consolidation phase 175) and non-neutropenic 35 (induction 16, consolidation 19). Clinical, microbiological and radiological evidence of infection could be identified in 64% of the febrile episodes (74% during induction, 52% during consolidation). Pulmonary infections were most common, both during induction and consolidation phase. Microbiologically gram-negative infections predominated. There were 60 possible/probable/definite episodes of fungal infection. Six cases of tuberculosis (pulmonary 5 and spine 1) and 3 cases of malaria (including one case of cerebral malaria) were also identified. Nineteen patients died (17 during induction, 2 during consolidation); 17 deaths were infection related, 12/17 possibly due to fungal infections. We suggest that evaluation of antibacterial resistance patterns in an institution must be done routinely in order to choose empiric antibiotics therapy. Careful selection of antibiotics and early institution of antifungal therapy besides considering alternative diagnosis peculiar to the region (e.g. tuberculosis, malaria) may help in reducing morbidity and mortality during AML therapy.Keywords
This publication has 44 references indexed in Scilit:
- Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 casesEuropean Journal of Haematology, 2008
- Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patientsJournal of Infection, 2007
- Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignanciesJournal of Infection, 2006
- Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltratesCancer, 2004
- Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93Leukemia, 2003
- Current Trends in the Epidemiology of Nosocomial Bloodstream Infections in Patients with Hematological Malignancies and Solid Neoplasms in Hospitals in the United StatesClinical Infectious Diseases, 2003
- Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxisThe Hematology Journal, 2003
- Antibiotic Treatment of Febrile Episodes in Neutropenic Cancer PatientsDrugs, 1997
- Prophylaxis with Fluoroquinolones for Bacterial Infections in Neutropenic Patients: A Meta-AnalysisClinical Infectious Diseases, 1996
- Predominance of Gram-Positive Microorganisms as a Cause of Septicemia in Patients with Hematological MalignanciesInfection Control & Hospital Epidemiology, 1994